WebBCRX Complete BioCryst Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. WebJan 9, 2024 · RESEARCH TRIANGLE PARK, N.C., Jan. 09, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced preliminary, unaudited ORLADEYO ® (berotralstat) net revenue for the fourth quarter and full year 2024 and provided guidance for full year 2024 ORLADEYO net revenue and expected peak …
BioCryst Pharmaceuticals (BCRX) Expected to Beat Earnings …
Web16 hours ago · The technique has proven to be very useful for finding positive surprises. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of ... WebMar 24, 2024 · RESEARCH TRIANGLE PARK, N.C. - BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) announced that oral, once-daily ORLADEYO (berotralstat) is now available for patients with a prescription in Germany. ORLADEYO was approved by the European Medicines Agency (EMA) on April 30, 2024 for the prevention of recurrent hereditary … mcgee distributing
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Given Average ...
WebApr 14, 2024 · In other BioCryst Pharmaceuticals news, CEO Jon P. Stonehouse sold 100,000 shares of the company’s stock in a transaction that occurred on Wednesday, February 1st. The stock was sold at an ... WebApr 5, 2024 · See the latest BioCryst Pharmaceuticals Inc stock price (NASDAQ:BCRX), related news, valuation, dividends and more to help you make your investing decisions. WebMar 31, 2024 · BioCryst Pharmaceuticals, Inc. Common Stock (BCRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Skip to … libby horton